$1.490
-0.020 (-1.32%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
BioRestorative Therapies Inc (BRTX) Moving Averages Convergence Divergence (MACD) indicator is -0.21, suggesting BRTX is Strong sell.
BioRestorative Therapies Inc (BRTX) 20-Day simple moving average is 1.51, while BioRestorative Therapies Inc (BRTX) share price is $—, making it Sell.
BioRestorative Therapies Inc (BRTX) 60-Day simple moving average is 2.53, while BioRestorative Therapies Inc (BRTX) share price is $—, making it Sell.
Technical Analysis for BRTX
AI Technical BRTXAs of 2026-11-07, the technical board for BioRestorative Therapies Inc (BRTX) reads strong sell: 1 indicators are flashing buy, 8 are indicating sell, and 4 are neutral. Price at $1.49 sits below the 5-day, 20-day, 60-day and 200-day moving averages and above the 10-day.
Momentum readings: RSI stands at 38.402, MACD stands at -0.211 (Sell), Stochastic %K stands at 49.796, Stochastic %D stands at 48.783 and CCI stands at 28.152.
BRTX trades below the 60-day SMA (2.53) and below the 200-day SMA (5.65). Immediate resistance sits at Classic R1 1.63, then R2 1.78. Support sits at Classic S1 1.34, then S2 1.20.
BioRestorative Therapies Inc (BRTX) Support & Resistance Level
BioRestorative Therapies Inc (BRTX) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 38.402 |
| STOCHk_14_3_3 | 49.796 |
| STOCHd_14_3_3 | 48.783 |
| CCI_20 | 28.152 |
| AO_5_34 | -0.299 |
| MOM_10 | -0.057 |
| MACD_12_26_9 | -0.211 |
BioRestorative Therapies Inc (BRTX) Relative Strength Index (RSI_14) is 38.402, creating a Neutral signal.
BioRestorative Therapies Inc (BRTX) Stochastic %K is 49.796, creating a Neutral signal.
BioRestorative Therapies Inc (BRTX) Stochastic %D is 48.783, creating a Neutral signal.
BioRestorative Therapies Inc (BRTX) CCI_20 is 28.152, creating a Neutral signal.
BioRestorative Therapies Inc (BRTX) Awesome Oscillator (AO) is -0.299, creating a Sell signal.
BioRestorative Therapies Inc (BRTX) Momentum (MOM) is -0.057, creating a Sell signal.
BioRestorative Therapies Inc (BRTX) Moving Average Convergence Divergence (MACD) is -0.211, creating a Sell signal.
BioRestorative Therapies Inc (BRTX) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 1.503 | Sell |
| MA_10 | 1.472 | Buy |
| MA_20 | 1.510 | Sell |
| MA_60 | 2.528 | Sell |
| MA_200 | 5.650 | Sell |
| MA_250 | 9.151 | Sell |
BioRestorative Therapies Inc (BRTX) 5-Day simple moving average is 1.503, while BioRestorative Therapies Inc (BRTX) share price is $, making it a Sell.
BioRestorative Therapies Inc (BRTX) 10-Day simple moving average is 1.472, while BioRestorative Therapies Inc (BRTX) share price is $, making it a Buy.
BioRestorative Therapies Inc (BRTX) 20-Day simple moving average is 1.510, while BioRestorative Therapies Inc (BRTX) share price is $, making it a Sell.
BioRestorative Therapies Inc (BRTX) 60-Day simple moving average is 2.528, while BioRestorative Therapies Inc (BRTX) share price is $, making it a Sell.
BioRestorative Therapies Inc (BRTX) 200-Day simple moving average is 5.650, while BioRestorative Therapies Inc (BRTX) share price is $, making it a Sell.
BioRestorative Therapies Inc (BRTX) 250-Day simple moving average is 9.151, while BioRestorative Therapies Inc (BRTX) share price is $, making it a Sell.
Related articles
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.